We are live on ! Find out more
IDXX icon

Idexx Laboratories

484 hedge funds and large institutions have $9.26B invested in Idexx Laboratories in 2016 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 150 increasing their positions, 187 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 19

29% more funds holding in top 10

Funds holding in top 10: 1418 (+4)

21% more capital invested

Capital invested by funds: $7.69B → $9.26B (+$1.58B)

11% more funds holding

Funds holding: 438484 (+46)

20% less repeat investments, than reductions

Existing positions increased: 150 | Existing positions reduced: 187

48% less call options, than puts

Call options by funds: $9.22M | Put options by funds: $17.9M

Holders
484
Holders Change
+46
Holders Change %
+10.5%
% of All Funds
12.88%
Holding in Top 10
18
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+28.57%
% of All Funds
0.48%
New
69
Increased
150
Reduced
187
Closed
19
Calls
$9.22M
Puts
$17.9M
Net Calls
-$8.63M
Net Calls Change
-$10.6M

IDXX Hedge Fund Activity: Q3 2016 in Review

484 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2016, worth a combined $9.26B — up 21% from $7.69B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new IDXX positions and 19 closed out — a net gain of 50 holders — while 150 added to existing stakes and 187 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $29.7M. The largest seller was Select Equity Group, cutting an estimated $76.3M.

  • 484 institutional investors held Idexx Laboratories (IDXX) as of Q3 2016, up from 438 in Q2 2016.
  • Funds reported $9.26B of Idexx Laboratories stock for Q3 2016, up 21% quarter-over-quarter.
  • 69 funds opened new Idexx Laboratories positions in Q3 2016 and 19 closed out, a net change of +50 holders.
  • The largest Idexx Laboratories buyer in Q3 2016 was Arrowstreet Capital, an estimated $29.7M added.
  • The largest Idexx Laboratories seller in Q3 2016 was Select Equity Group, an estimated $76.3M sold.

Based on aggregated 13F filings for Q3 2016.